Tsukuba, Japan

Naomoto Harada

This inventor holds 1 USPTO granted patent. Top assignee: Msd K.k.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomoto Harada. Retrieved from https://idiyas.com/inventor/naomoto-harada-d7hfydng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naomoto Harada: Innovator in Gene Modification

Introduction

Naomoto Harada is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of genetic engineering, particularly in the study of the MGAT2 gene. His work focuses on developing gene-modified non-human animals that can aid in understanding the functions of this gene in vivo.

Latest Patents

Harada holds a patent for an animal having a modification in the MGAT2 gene. This invention aims to provide a gene-modified non-human animal with an inactivated MGAT2 gene, which is essential for researching the gene's function. Additionally, it includes methods for screening compounds that can inhibit the activity of MGAT2, as well as detecting diseases induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. This innovative approach allows for the prevention or treatment of diseases related to lipid metabolism.

Career Highlights

Naomoto Harada is associated with MSD K.K., where he continues to advance his research in genetic modifications. His work has garnered attention for its potential applications in medical research and therapeutic developments.

Collaborations

Harada collaborates with notable colleagues, including Yoshiki Ito and Yoshitaka Tamai. Their combined expertise contributes to the innovative research being conducted in the field of genetic engineering.

Conclusion

Naomoto Harada's contributions to genetic engineering, particularly through his patent on the MGAT2 gene, highlight his role as a key innovator in this field. His work not only enhances our understanding of genetic functions but also opens avenues for potential medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…